Arning L - Search Results

1

PGC-1alpha as modifier of onset age in Huntington disease.

Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L. Taherzadeh-Fard E, et al. Among authors: arning l. Mol Neurodegener. 2009 Feb 6;4:10. doi: 10.1186/1750-1326-4-10. Mol Neurodegener. 2009. PMID: 19200361 Free PMC article.

2

A novel splice site mutation in the TRIM37 gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity.

Jagiello P, Hammans C, Wieczorek S, Arning L, Stefanski A, Strehl H, Epplen JT, Gencik M. Jagiello P, et al. Among authors: arning l. Hum Mutat. 2003 Jun;21(6):630-5. doi: 10.1002/humu.10220. Hum Mutat. 2003. PMID: 12754710

3

New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes.

Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, Gross WL, Epplen JT. Jagiello P, et al. Among authors: arning l. Hum Genet. 2004 Apr;114(5):468-77. doi: 10.1007/s00439-004-1092-z. Epub 2004 Feb 14. Hum Genet. 2004. PMID: 14968360

4

Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.

Arning L, Jagiello P, Wieczorek S, Saft C, Andrich J, Epplen JT. Arning L, et al. BMC Med Genet. 2004 Mar 24;5:7. doi: 10.1186/1471-2350-5-7. BMC Med Genet. 2004. PMID: 15040808 Free PMC article.

5

Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA.

Wieczorek S, Jagiello P, Arning L, Dahmen N, Epplen JT. Wieczorek S, et al. Among authors: arning l. J Mol Med (Berl). 2004 Oct;82(10):696-705. doi: 10.1007/s00109-004-0569-5. Epub 2004 Aug 7. J Mol Med (Berl). 2004. PMID: 15309313

6

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.

Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT. Arning L, et al. Neurogenetics. 2005 Feb;6(1):25-8. doi: 10.1007/s10048-004-0198-8. Epub 2004 Nov 17. Neurogenetics. 2005. PMID: 15742215

7

Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD).

Arning L, Kraus PH, Saft C, Andrich J, Epplen JT. Arning L, et al. BMC Med Genet. 2005 Oct 3;6:35. doi: 10.1186/1471-2350-6-35. BMC Med Genet. 2005. PMID: 16202123 Free PMC article.

8

Is the retina affected in Huntington disease?

Petrasch-Parwez E, Saft C, Schlichting A, Andrich J, Napirei M, Arning L, Wieczorek S, Dermietzel R, Epplen JT. Petrasch-Parwez E, et al. Among authors: arning l. Acta Neuropathol. 2005 Nov;110(5):523-5. doi: 10.1007/s00401-005-1092-7. Epub 2005 Oct 13. Acta Neuropathol. 2005. PMID: 16222522 No abstract available.

9

The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.

Metzger S, Bauer P, Tomiuk J, Laccone F, Didonato S, Gellera C, Soliveri P, Lange HW, Weirich-Schwaiger H, Wenning GK, Melegh B, Havasi V, Balikó L, Wieczorek S, Arning L, Zaremba J, Sulek A, Hoffman-Zacharska D, Basak AN, Ersoy N, Zidovska J, Kebrdlova V, Pandolfo M, Ribaï P, Kadasi L, Kvasnicova M, Weber BH, Kreuz F, Dose M, Stuhrmann M, Riess O. Metzger S, et al. Among authors: arning l. Neurogenetics. 2006 Mar;7(1):27-30. doi: 10.1007/s10048-005-0023-z. Epub 2005 Dec 21. Neurogenetics. 2006. PMID: 16369839

10

Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.

Hansen W, Saft C, Andrich J, Müller T, Wieczorek S, Epplen JT, Arning L. Hansen W, et al. Among authors: arning l. J Negat Results Biomed. 2005 Dec 22;4:12. doi: 10.1186/1477-5751-4-12. J Negat Results Biomed. 2005. PMID: 16372906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters